Impending Relief for Medicare Beneficiaries — The Inflation Reduction Act-Reference-Cited by-同舟云学术

Impending Relief for Medicare Beneficiaries — The Inflation Reduction Act

Published:2022-10-20 Issue:16 Volume:387 Page:1437-1439
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Dusetzina Stacie B.¹,Huskamp Haiden A.¹

Affiliation:

1. From the Department of Health Policy and the Vanderbilt–Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville (S.B.D.); and the Department of Health Care Policy, Harvard Medical School, Boston (H.A.H.).

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMp2211223

Reference1 articles.

1. Many Medicare Beneficiaries Do Not Fill High-Price Specialty Drug Prescriptions

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accelerated Approval for Cancer Drugs in the United States and the Clinical Evidence Required for Conversion to Regular Approval;Journal of Pharmaceutical Innovation;2024-09-04

2. Cost trends of metastatic renal cell carcinoma therapy: the impact of oral anticancer agents and immunotherapy;JNCI Cancer Spectrum;2024-08-12

3. Addressing financial toxicity in cancer treatment—An opportunity for the 340B drug pricing program;Cancer;2024-05-28

4. Pharmacy Assistance Programs for Oral Anticancer Drugs: A Narrative Review;JCO Oncology Practice;2024-04

5. Access to Financial Assistance Programs and Their Impact on Overall Spending on Oral Anticancer Medications at an Integrated Specialty Pharmacy;JCO Oncology Practice;2024-02